ERBB2 and breast neoplasm: The dataset GSE130788, relative to the TRIO-B-07 clinical trial (NCT#00769470) [45], compared the gene expression profiles of HER2+ breast tumors (N = 199 samples) at baseline and after three trastuzumab-based NAC regimens (S2I Fig).